Prograf and Endocarditis bacterial - a phase IV clinical study of FDA data

Summary:

Endocarditis bacterial is reported as a side effect among people who take Prograf (tacrolimus), especially for people who are male, 20-29 old, also take Orthoclone Okt3, and have Idiopathic thrombocytopenic purpura.

The phase IV clinical study analyzes which people have Endocarditis bacterial when taking Prograf. It is created by eHealthMe based on reports of 41,725 people who have side effects when taking Prograf from the FDA, and is updated regularly.

What is Prograf?

Prograf has active ingredients of tacrolimus. It is often used in kidney transplant. eHealthMe is studying from 42,230 Prograf users. Check the latest studies of Prograf.

What is Endocarditis bacterial?

Endocarditis bacterial (an inflammation of the inner layer of the heart by bacterial infection) is found to be associated with 161 drugs and 246 conditions by eHealthMe. Check the latest studies of Endocarditis bacterial.

On Jul, 23, 2026

41,725 people reported to have side effects when taking Prograf.
Among them, 11 people (0.03%) have Endocarditis bacterial.

Could Prograf cause Endocarditis bacterial?

Among these 11 people:

What is the gender of people who have Endocarditis bacterial when taking Prograf? *

female: 18.18 %
male: 81.82 %

What is the age of people who have Endocarditis bacterial when taking Prograf? *

What are other drugs people take besides Prograf? *

What are other side effects people have besides Endocarditis bacterial? *

Weakness: 3 people, 27.27%
Pain: 3 people, 27.27%
Acute Kidney Failure: 3 people, 27.27%
Anaemia (lack of blood): 3 people, 27.27%
Bronchopulmonary Aspergillosis (lung disorder caused by aspergillus fungi): 3 people, 27.27%
Chronic Renal Failure (kidney failure): 3 people, 27.27%
Cytomegalovirus Infection: 3 people, 27.27%
Depression: 3 people, 27.27%
Fever: 3 people, 27.27%
Gastric Perforation (hole in stomach): 3 people, 27.27%

What are the existing conditions these people have? *

Idiopathic Thrombocytopenic Purpura (bleeding disorder in which the immune system destroys platelets, which are necessary for normal blood clotting): 2 people, 18.18%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 9.09%
Acute Graft Versus Host Disease (acute complication following an allogeneic tissue/blood transplant): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Prograf and have Endocarditis bacterial?

- Check whether Endocarditis bacterial is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Prograf:

Prograf (42,230 reports)

Browse all side effects of Prograf:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Endocarditis bacterial:

Endocarditis bacterial (161 drugs)

Browse all the conditions that are associated with Endocarditis bacterial:

Endocarditis bacterial (246 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on tacrolimus (the active ingredients of Prograf) and Prograf (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.